News

News

CT systems, X-ray phase tomography, AIP publishing

X-ray phase tomography is an imaging technique that uses penetrating X-rays to create volumetric views through "slices" or sections of soft biological tissues, such as tumors, and it offers...

FFR catheters, Cath lab, OptoWire, OptoMonitor

The OptoWire and OptoMonitor are Opsens’ products for FFR measurements to optimize the diagnosis and guide the therapy in patients with coronary heart disease.

More than 10 percent of patients treated with aspirin therapy for primary cardiovascular disease prevention were likely inappropriately prescribed medication, according to a new study in the...

ultrasound, market, cardiovascular, 3-D, 4-D, United States, U.S.

According to a new report by iData Research, ultrasound equipment providers in the United States are likely to see stable, reliable growth in the coming years. Already a billion-dollar...

HeartFlow, CT-FFR, computed tomography fractional flow reserve, UH Case Medical

University Hospitals (UH) Case Medical is now offering a new, non-invasive test for coronary artery disease designed to help physicians develop the right treatment plan for each patient. Developed...

Our daily diet may help lower bad cholesterol, in turn reducing risk for heart disease, according to health researchers in the Jan. 7 edition of the Journal of the American Heart Association...

Ambry Genetics, genetic testing, CardioNext, HCM, Rhythm

Ambry Genetics announces the launch of cardiovascular genetic testing panels for inherited cardiomyopathies and arrhythmias. These feature an intuitive, tiered approach to testing for...

Savaysa, Daiichi Sankyo, edoxaban, FDA, approval, NVAF, thromboembolism

Daiichi Sankyo Co. Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Savaysa (edoxaban) tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of...

Balloon catheters, cath lab, peripheral artery disease (PAD), Lithoplasty

Lithoplasty is a balloon-based technology that utilizes integrated lithotripsy to disrupt both superficial and deep calcium and normalize vessel wall compliance prior to low-pressure balloon...

ECRI 2015 Top 10 Hospital C-Suite Watch List, 3-D printing, Telemedicine

ECRI Institute’s 2015 Top 10 Hospital C-Suite Watch List, available as a free public service, answers key questions on new and emerging health technologies that potentially provide new...

CardioFocus, HeartLight Endoscopic Ablation System, Japan Lifeline, distribution

CardioFocus Inc., developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation (AF), announced that it has executed an exclusive, multi-year distribution...

Transcatheter Technologies GmbH has announced that it is expanding its product family to include Tresillo, a transcatheter mitral valve implantation (TMVI) version. 

Ablation Systems, Atrial Fibrillation, EP Lab, Clinical Trial/Study

Medtronic, Inc. announced the initiation of a randomized clinical trial in Europe to assess the benefits of ablation using the Medtronic Artic Front Advance cryoballoon as a first-line treatment...

Gore Medical, Gore Viabahn Endoprosthesis, CE Mark, stent grafts

W. L. Gore & Associates Inc. announced that the Gore Viabahn Endoprosthesis has received CE Mark approval to improve blood flow in symptomatic obstruction of peripheral veins,...

CardioKinetix, Parachute, PARACHUTE III, heart failure, clinical trial

CardioKinetix Inc. announced results of a pooled analysis study of the catheter-based Parachute ventricular partitioning device. Twelve-month clinical data from PARACHUTE III, a study of 100...

heart Failure, CHI Franciscan, Healthcare Colloquium

The Healthcare Colloquium announced that CHI Franciscan Health is the first Accredited Heart Failure System in the Northwest. 

Covidien announced it has received CE Mark approval for its Stellarex drug-coated angioplasty balloon (DCB). 

At the IEEE medical Imaging Conference (MIC) in November, ContextVision co-presented with Texas Instruments and High Performance Consulting on new research on 3-D adaptive...

Patient Monitoring, Remote Monitoring

Medtronic's roughly $43 billion acquisition and merger with Covidien has been widely discussed in the media for its U.S. Federal tax implications, but it's also creating a stronger leading player...

Stents, Self-Apposing Stent, Stentys

Stentys announced that the Self-Apposing Stent has been implanted more than 10,000 times in patients worldwide